Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04458051
Brief Title: Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

First Submitted : July 1, 2020
First Submitted that Met QC Criteria : July 1, 2020
First Posted : July 7, 2020

Last Update Submitted that Met QC Criteria : June 23, 2021
Last Update Posted : June 24, 2021 (Estimate)